These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1184 related items for PubMed ID: 27146090

  • 1. Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA.
    Warner WA, Kuang SN, Hernandez R, Chong MC, Ewing PJ, Fleischer J, Meng J, Chu S, Terashita D, English L, Chen W, Xu HH.
    BMC Infect Dis; 2016 May 04; 16():194. PubMed ID: 27146090
    [Abstract] [Full Text] [Related]

  • 2. OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq.
    Ganjo AR, Maghdid DM, Mansoor IY, Kok DJ, Severin JA, Verbrugh HA, Kreft D, Fatah MH, Alnakshabandi AA, Dlnya A, Hammerum AM, Ng K, Goessens W.
    Microb Drug Resist; 2016 Dec 04; 22(8):627-637. PubMed ID: 27003287
    [Abstract] [Full Text] [Related]

  • 3. Phenotypic and molecular characterization of Acinetobacter baumannii clinical isolates from nosocomial outbreaks in Los Angeles County, California.
    Valentine SC, Contreras D, Tan S, Real LJ, Chu S, Xu HH.
    J Clin Microbiol; 2008 Aug 04; 46(8):2499-507. PubMed ID: 18524965
    [Abstract] [Full Text] [Related]

  • 4. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
    Keskin H, Tekeli A, Dolapci İ, Öcal D.
    Mikrobiyol Bul; 2014 Jul 04; 48(3):365-76. PubMed ID: 25052103
    [Abstract] [Full Text] [Related]

  • 5. Antimicrobial Resistance Mechanisms and Genetic Diversity of Multidrug-Resistant Acinetobacter baumannii Isolated from a Teaching Hospital in Malaysia.
    Biglari S, Hanafiah A, Mohd Puzi S, Ramli R, Rahman M, Lopes BS.
    Microb Drug Resist; 2017 Jul 04; 23(5):545-555. PubMed ID: 27854165
    [Abstract] [Full Text] [Related]

  • 6. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
    Nemec A, Krízová L, Maixnerová M, Diancourt L, van der Reijden TJ, Brisse S, van den Broek P, Dijkshoorn L.
    J Antimicrob Chemother; 2008 Sep 04; 62(3):484-9. PubMed ID: 18477708
    [Abstract] [Full Text] [Related]

  • 7. The emergence of a novel sequence type of MDR Acinetobacter baumannii from the intensive care unit of an Egyptian tertiary care hospital.
    Ghaith DM, Zafer MM, Al-Agamy MH, Alyamani EJ, Booq RY, Almoazzamy O.
    Ann Clin Microbiol Antimicrob; 2017 May 10; 16(1):34. PubMed ID: 28486994
    [Abstract] [Full Text] [Related]

  • 8. High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa - an update.
    Lowings M, Ehlers MM, Dreyer AW, Kock MM.
    BMC Infect Dis; 2015 Nov 14; 15():521. PubMed ID: 26573617
    [Abstract] [Full Text] [Related]

  • 9. Outbreak of imipenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex harboring different carbapenemase gene-associated genetic structures in an intensive care unit.
    Lee YT, Fung CP, Wang FD, Chen CP, Chen TL, Cho WL.
    J Microbiol Immunol Infect; 2012 Feb 14; 45(1):43-51. PubMed ID: 22169123
    [Abstract] [Full Text] [Related]

  • 10. Molecular epidemiology of a clonal outbreak of multidrug-resistant Acinetobacter baumannii in a university hospital in Italy.
    Zarrilli R, Casillo R, Di Popolo A, Tripodi MF, Bagattini M, Cuccurullo S, Crivaro V, Ragone E, Mattei A, Galdieri N, Triassi M, Utili R.
    Clin Microbiol Infect; 2007 May 14; 13(5):481-9. PubMed ID: 17430339
    [Abstract] [Full Text] [Related]

  • 11. A diversity of OXA-carbapenemases and class 1 integrons among carbapenem-resistant Acinetobacter baumannii clinical isolates from Sweden belonging to different international clonal lineages.
    Karah N, Giske CG, Sundsfjord A, Samuelsen Ø.
    Microb Drug Resist; 2011 Dec 14; 17(4):545-9. PubMed ID: 21830948
    [Abstract] [Full Text] [Related]

  • 12. Molecular epidemiology, antimicrobial susceptibility and carbapenemase resistance determinants among Acinetobacter baumannii clinical isolates in Taiwan.
    Chuang YC, Sheng WH, Lauderdale TL, Li SY, Wang JT, Chen YC, Chang SC.
    J Microbiol Immunol Infect; 2014 Aug 14; 47(4):324-32. PubMed ID: 23726465
    [Abstract] [Full Text] [Related]

  • 13. OXA-23 and ISAba1-OXA-66 class D β-lactamases in Acinetobacter baumannii isolates from companion animals.
    Ewers C, Klotz P, Leidner U, Stamm I, Prenger-Berninghoff E, Göttig S, Semmler T, Scheufen S.
    Int J Antimicrob Agents; 2017 Jan 14; 49(1):37-44. PubMed ID: 27890443
    [Abstract] [Full Text] [Related]

  • 14. Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals.
    Agodi A, Voulgari E, Barchitta M, Quattrocchi A, Bellocchi P, Poulou A, Santangelo C, Castiglione G, Giaquinta L, Romeo MA, Vrioni G, Tsakris A.
    J Hosp Infect; 2014 Apr 14; 86(4):260-6. PubMed ID: 24680473
    [Abstract] [Full Text] [Related]

  • 15. Dissemination of multidrug-resistant Acinetobacter baumannii carrying BlaOxA-23 from hospitals in central Taiwan.
    Lee MH, Chen TL, Lee YT, Huang L, Kuo SC, Yu KW, Hsueh PR, Dou HY, Su IJ, Fung CP.
    J Microbiol Immunol Infect; 2013 Dec 14; 46(6):419-24. PubMed ID: 23010539
    [Abstract] [Full Text] [Related]

  • 16. Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit.
    Tsakris A, Ikonomidis A, Poulou A, Spanakis N, Vrizas D, Diomidous M, Pournaras S, Markou F.
    Clin Microbiol Infect; 2008 Jun 14; 14(6):588-94. PubMed ID: 18397334
    [Abstract] [Full Text] [Related]

  • 17. A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features.
    Boral B, Unaldi Ö, Ergin A, Durmaz R, Eser ÖK, Acinetobacter Study Group.
    Ann Clin Microbiol Antimicrob; 2019 Jul 02; 18(1):19. PubMed ID: 31266519
    [Abstract] [Full Text] [Related]

  • 18. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
    Wang H, Guo P, Sun H, Wang H, Yang Q, Chen M, Xu Y, Zhu Y.
    Antimicrob Agents Chemother; 2007 Nov 02; 51(11):4022-8. PubMed ID: 17846127
    [Abstract] [Full Text] [Related]

  • 19. Clinical epidemiology and resistance mechanisms of carbapenem-resistant Acinetobacter baumannii, French Guiana, 2008-2014.
    Mahamat A, Bertrand X, Moreau B, Hommel D, Couppie P, Simonnet C, Kallel H, Demar M, Djossou F, Nacher M.
    Int J Antimicrob Agents; 2016 Jul 02; 48(1):51-55. PubMed ID: 27236843
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.